MENU
+Compare
HIMS
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$47.98
Change
+$0.52 (+1.10%)
Capitalization
3.31B

HIMS Hims & Hers Health Forecast, Technical & Fundamental Analysis

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more... Show more

HIMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HIMS with price predictions
Jul 03, 2025

HIMS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 23, 2025

HIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where HIMS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMS advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HIMS as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HIMS turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

HIMS moved below its 50-day moving average on July 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIMS crossed bearishly below the 50-day moving average on July 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIMS entered a downward trend on July 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.756) is normal, around the industry mean (17.380). P/E Ratio (0.000) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.832). Dividend Yield (0.000) settles around the average of (0.107) among similar stocks. P/S Ratio (3.759) is also within normal values, averaging (116.662).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
HIMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HIMS is expected to report earnings to fall 23.30% to 15 cents per share on August 11

Hims & Hers Health HIMS Stock Earnings Reports
Q2'25
Est.
$0.15
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.22
Q2'24
Beat
by $0.02
The last earnings report on May 05 showed earnings per share of 20 cents, missing the estimate of 23 cents. With 17.39M shares outstanding, the current market capitalization sits at 3.31B.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry HouseholdPersonalCare

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSLX15.920.17
+1.08%
NYLI Fiera SMID Growth Class C
VISGX79.160.80
+1.02%
Vanguard Small Cap Growth Index Inv
RUSTX17.490.15
+0.87%
Russell Inv US Strategic Equity M
MXMVX14.320.07
+0.49%
Empower Mid Cap Value Inv
RYCFX40.910.11
+0.27%
Rydex Biotechnology C

HIMS and Stocks

Correlation & Price change

A.I.dvisor tells us that HIMS and EWCZ have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and EWCZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
+0.04%
EWCZ - HIMS
29%
Poorly correlated
+1.40%
HNST - HIMS
28%
Poorly correlated
N/A
IPAR - HIMS
26%
Poorly correlated
+0.83%
SKIN - HIMS
23%
Poorly correlated
+8.06%
SPB - HIMS
21%
Poorly correlated
+0.25%
More